On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Lyndra Therapeutics (United States)

InstitutionResearch output, impact & collaborations

Lyndra Therapeutics (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Lyndra Therapeutics (United States)?

ScholarIQrecord summary

Lyndra Therapeutics (United States) is a research organisation in Watertown, United States. OpenAlex records 42 works and 2,212 citations for it. 1 researchers list it as their most recent affiliation.

How many works does Lyndra Therapeutics (United States) have?

ScholarIQindexed works

Lyndra Therapeutics (United States) has 42 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Lyndra Therapeutics (United States) have?

ScholarIQcitation count

Lyndra Therapeutics (United States) has 2,212 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Lyndra Therapeutics (United States)?

ScholarIQresearcher count

Lyndra Therapeutics (United States) has 1 researchers in the ScholarIQ index.

What is the average h-index at Lyndra Therapeutics (United States)?

ScholarIQavg h-index

Lyndra Therapeutics (United States) has an average h-index of 62 in OpenAlex.

What is the ROR of Lyndra Therapeutics (United States)?

ScholarIQror

The ROR for Lyndra Therapeutics (United States) is on the source record.

What is the OpenAlex record for Lyndra Therapeutics (United States)?

ScholarIQopenalex

The OpenAlex for Lyndra Therapeutics (United States) is on the source record.

Who are the most-cited researchers behind Lyndra Therapeutics (United States)?

ScholarIQtop researchers by citations
1
David Raben · Head and Neck Cancer Studies
454 works23,076 citations

What are the most-cited papers on Lyndra Therapeutics (United States)?

ScholarIQmost cited works
Prostate Cancer, Version 1.2016
James L. Mohler, Andrew J. Armstrong, Robert R. Bahnson, Anthony V. D’Amico, Brian J. Davis, James A. Eastham, Charles A. Enke, Thomas A. Farrington, Celestia S. Higano, Eric M. Horwitz, Michael E. Hurwitz, Christopher J. Kane, Mark H. Kawachi, Michael Kuettel, Richard J. Lee, Joshua J. Meeks, David F. Penson, Elizabeth R. Plimack, Julio M. Pow‐Sang, David Raben, Sylvia Richey, Mack Roach, Stan Rosenfeld, Edward M. Schaeffer, Ted A. Skolarus, Eric J. Small, Guru Sonpavde, Sandy Srinivas, Seth A. Strope, Jonathan D. Tward, Dorothy A. Shead, Deborah A. Freedman-Cass
Journal of the National Comprehensive Cancer Network. 2016656 Citations
Prostate Cancer, Version 2.2014
James L. Mohler, Philip W. Kantoff, Andrew J. Armstrong, Robert R. Bahnson, Michael B. Cohen, Anthony V. D’Amico, James A. Eastham, Charles A. Enke, Thomas A. Farrington, Celestia S. Higano, Eric M. Horwitz, Christopher J. Kane, Mark H. Kawachi, Michael Kuettel, Timothy M. Kuzel, Richard J. Lee, Arnold W. Malcolm, David C. Miller, Elizabeth R. Plimack, Julio M. Pow‐Sang, David Raben, Sylvia Richey, Mack Roach, Eric Rohren, Stan Rosenfeld, Edward M. Schaeffer, Eric J. Small, Guru Sonpavde, Sandy Srinivas, Cy A. Stein, Seth A. Strope, Jonathan D. Tward, Dorothy A. Shead, Maria Ho
Journal of the National Comprehensive Cancer Network. 2014334 Citations

How much of the research on Lyndra Therapeutics (United States) is open access?

ScholarIQopen access share
0%OPEN ACCESS
Gold
0%
Green
0%
Hybrid
0%
Bronze
0%
Closed
100%
470M+ articles · free account